Evidence map›Paper›PMID 39594798›Full record

ArticleCancers2024

PSMA-Guided Imaging and Therapy of Advanced Adenoid Cystic Carcinomas and Other Salivary Gland Carcinomas.

Nils F Trautwein, Andreas Brendlin, Gerald Reischl, Moritz Mattke, Frank Paulsen, Hubert Loewenheim, Lars Zender, Christian la Fougère, Helmut Dittmann

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Nils F TrautweinDepartment of Nuclear Medicine and Clinical Molecular Imaging, University of Tübingen, 72074 Tübingen, Germany.ORCID 0000-0003-3397-6299
Andreas BrendlinDepartment of Diagnostic and Interventional Radiology, University of Tübingen, 72074 Tübingen, Germany.ORCID 0000-0002-5961-9727
Gerald ReischlDepartment of Preclinical Imaging and Radiopharmacy, Werner Siemens Imaging Center, 72076 Tübingen, Germany.
Moritz MattkeDepartment of Nuclear Medicine and Clinical Molecular Imaging, University of Tübingen, 72074 Tübingen, Germany.
Frank PaulsenDepartment of Radiation Oncology, University Hospital, 72076 Tuebingen, Germany.
Hubert LoewenheimDepartment of Otolaryngology-Head & Neck Surgery, University of Tübingen Medical Center, 72076 Tübingen, Germany.
Lars ZenderCluster of Excellence iFIT (EXC 2180) "Image-Guided and Functionally Instructed Tumor Therapies", University of Tübingen, 72074 Tübingen, Germany.
Christian la FougèreDepartment of Nuclear Medicine and Clinical Molecular Imaging, University of Tübingen, 72074 Tübingen, Germany.ORCID 0000-0001-7519-0417
Helmut DittmannDepartment of Nuclear Medicine and Clinical Molecular Imaging, University of Tübingen, 72074 Tübingen, Germany.ORCID 0000-0001-6840-5571

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

SGCs are rare malignancies, accounting for less than 1% of all head and neck cancers [...].

Indexed as

adenoid cystic carcinomas (ACCs)PETPSMA-RLTsalivary gland carcinomas (SGCs)

Identifiers

PMID39594798
PMCPMC11592976

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.